Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Theravance Biopharma U.S., Inc. 401(K) Plan is a benefit plan reported by Theravance Biopharma U.S., Inc. under EIN 46-3451245 and plan number 001. The latest loaded filing year is 2023. The filing reports 430 participants and $75,157,740 in end-of-year plan assets, where available in the loaded dataset.
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $75,157,740
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $75,157,740
- Net assets (BOY)
- $65,934,565
Income & contributions
- Employer contributions
- $478,215
- Participant contributions
- $2,208,907
- Total contributions
- $2,688,660
- Total income / additions
- $15,499,778
Expenses & distributions
- Benefits paid
- $6,250,791
- Administrative expenses
- $18,336
- Total expenses
- $6,276,603
- Net increase / (decrease)
- $9,223,175